Literature DB >> 24184647

Health risks related to dual use of cigarettes and snus - a systematic review.

Peter N Lee1.   

Abstract

Reviews show that using snus (Swedish-type moist snuff) is much safer than smoking, with no increased risk from snus of cancer or circulatory disease yet demonstrated, but have not investigated possible health effects from dual use of cigarettes and snus. This review considers studies where health risks can be compared in dual users, those who only use snus or only smoke, and those who use neither product. The interaction RR, the ratio of RRs associated with snus use in smokers and in non-smokers, was used to test for special effects of dual use. Of 51 interaction RRs presented, only one (for gestational hypertension in a study based on the Swedish Medical Register) was significantly (p<0.05) above 1.0, and RRs below 1.0 were commoner, perhaps as cigarette consumption is lower in dual users than those who only smoke. Dual users more often initiate tobacco use with cigarettes than snus. Dual use is much commoner in adolescents than adults, possibly because many tobacco users try both products, eventually settling on one. Epidemiological evidence from various sources, though suffering from weaknesses, consistently suggests concomitant snus use increases smoking quit rates, and aligns with evidence from RCTs using snus to aid smoking cessation.
Copyright © 2013 The Author. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Circulatory disease; Smokeless; Tobacco

Mesh:

Year:  2013        PMID: 24184647     DOI: 10.1016/j.yrtph.2013.10.007

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  10 in total

1.  The US SimSmoke tobacco control policy model of smokeless tobacco and cigarette use.

Authors:  David T Levy; Zhe Yuan; Yameng Li
Journal:  BMC Public Health       Date:  2018-06-05       Impact factor: 3.295

2.  The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States.

Authors:  David T Levy; Ron Borland; Andrea C Villanti; Raymond Niaura; Zhe Yuan; Yian Zhang; Rafael Meza; Theodore R Holford; Geoffrey T Fong; K Michael Cummings; David B Abrams
Journal:  Nicotine Tob Res       Date:  2016-07-14       Impact factor: 4.244

3.  Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers.

Authors:  Matthew J Carpenter; Amy E Wahlquist; Jessica L Burris; Kevin M Gray; Elizabeth Garrett-Mayer; K Michael Cummings; Anthony J Alberg
Journal:  Tob Control       Date:  2016-04-12       Impact factor: 7.552

Review 4.  A systematic review of transitions between cigarette and smokeless tobacco product use in the United States.

Authors:  Jamie Tam; Hannah R Day; Brian L Rostron; Benjamin J Apelberg
Journal:  BMC Public Health       Date:  2015-03-18       Impact factor: 3.295

5.  Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities.

Authors:  Jose Antonio Baz-Lomba; Stefania Salvatore; Emma Gracia-Lor; Richard Bade; Sara Castiglioni; Erika Castrignanò; Ana Causanilles; Felix Hernandez; Barbara Kasprzyk-Hordern; Juliet Kinyua; Ann-Kathrin McCall; Alexander van Nuijs; Christoph Ort; Benedek G Plósz; Pedram Ramin; Malcolm Reid; Nikolaos I Rousis; Yeonsuk Ryu; Pim de Voogt; Jorgen Bramness; Kevin Thomas
Journal:  BMC Public Health       Date:  2016-10-01       Impact factor: 3.295

6.  Brief exposure to Swedish snus causes divergent vascular responses in healthy male and female volunteers.

Authors:  Lukasz Antoniewicz; Mirza Novo; Jenny Bosson; Magnus Lundbäck
Journal:  PLoS One       Date:  2018-04-18       Impact factor: 3.240

Review 7.  Snus: a compelling harm reduction alternative to cigarettes.

Authors:  Elizabeth Clarke; Keith Thompson; Sarah Weaver; Joseph Thompson; Grant O'Connell
Journal:  Harm Reduct J       Date:  2019-11-27

8.  Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor.

Authors:  Kari Hemminki; Asta Försti; Akseli Hemminki; Börje Ljungberg; Otto Hemminki
Journal:  BMC Cancer       Date:  2021-05-25       Impact factor: 4.430

9.  Does reduced smoking if you can't stop make any difference?

Authors:  Rachna Begh; Nicola Lindson-Hawley; Paul Aveyard
Journal:  BMC Med       Date:  2015-10-12       Impact factor: 8.775

10.  Do never smokers make up an increasing share of snus users as cigarette smoking declines? Changes in smoking status among male snus users in Norway 2003-15.

Authors:  Karl Erik Lund; Tord Finne Vedøy; Linda Bauld
Journal:  Addiction       Date:  2016-12-05       Impact factor: 6.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.